Results 271 to 280 of about 121,985 (386)

Poisonings With Opioids and Benzodiazepines in Denmark: A Retrospective Study From the Danish Poison Information Centre

Basic &Clinical Pharmacology &Toxicology, Volume 136, Issue 6, June 2025.
ABSTRACT Introduction This study describes opioid and benzodiazepine poisonings in Denmark from 2014 to 2022. The analgesic effect of opioids and sedative effect of benzodiazepines are used to treat pain, insomnia and anxiety disorders and can cause abuse and addiction.
Alba K. V. Sigfredsson, Dorte Fris Palmqvist, Kim Dalhoff   +2 more
wiley   +1 more source

Medicare Beneficiary Receipt of Methadone by Drive Time to Opioid Treatment Programs.

JAMA Netw Open
Cantor J, Hernandez HG, Kofner A, Lai J, Agniel D, Simon KI, Stein BD, Taylor EA.   +7 more
europepmc   +1 more source

The Relationship Between Methadone and Buprenorphine Enrollment and Overdose Prevention and Treatment Behaviors Among a Community Sample of People Who Use Opioids in Baltimore, Maryland. [PDF]

Int J Environ Res Public Health
Latkin CA, Dayton L, Davey-Rothwell M, Jones A.   +3 more
europepmc   +1 more source

Patterns of service use and treatment involvement of methadone maintenance patients

, 1997
Mindy Widman, Jerome J. Platt, Victor Lidz, Diane A. Mathis, David S. Metzger   +4 more
openalex   +1 more source

S14.01 Psychotherapy for opiate addicts in methadone substitution — A controlled trial [PDF]

, 2000
Norbert Scherbaum, Th. Finkbeiner, J. Kluwig, Dorothy Krause, B. Merget, Markus Gastpar   +5 more
openalex   +1 more source

ABCB1, SLC22A1, COMT, and OPRM1 genotypes: Study of their influence on plasma methadone levels and clinical response to methadone maintenance treatment in opioid use disorder

Fundamental &Clinical Pharmacology, Volume 39, Issue 3, June 2025.
Abstract Background Opioid use disorder (OUD) is an emerging and global public health concern, and its management remains inadequate, notably due to a lack of biomarkers, except for the CYP2B6 genetic polymorphisms. Objectives Hence, the aim of this study was to assess the influence of genetic polymorphisms of ABCB1, SLC22A1, COMT, and OPRM1 on ...
Abd El Kader Ait Tayeb, Edouard‐Jules Laforgue, Benoit Schreck, Marie Grall‐Bronnec, Jean‐Benoit Hardouin, Juliette Leboucher, OPAL Group, Caroline Victorri‐Vigneau, Céline Verstuyft   +8 more
wiley   +1 more source

New Synthesis and Pharmacological Evaluation of Enantiomerically Pure (<i>R</i>)- and (<i>S</i>)-Methadone Metabolites as <i>N</i>-Methyl-d-aspartate Receptor Antagonists. [PDF]

J Med Chem
Banzato M, Furlan A, Locatelli P, Sgrignani J, Ongaro A, Dolmella A, De Martin S, Comai S, Cavalli A, Inturrisi C, Bettini E, Manfredi PL, Mattarei A.   +12 more
europepmc   +1 more source

Exploration of Effective Substance Use Relapse Prevention Programmes for the Youth: An Integrative Literature Review

Journal of Psychiatric and Mental Health Nursing, Volume 32, Issue 3, Page 661-679, June 2025.
ABSTRACT Introduction Youth substance use has been associated with recurrent episodes of substance misuse. A large body of research has shown that relapsing into substance use is still a significant obstacle that prevents people who use substances and want to stop from recovering and abstaining.
Wada Gaolaolwe, Miriam Mmamphamo Moagi, Gaotswake Patience Kovane, Leepile Sehularo   +3 more
wiley   +1 more source

Impact of recent stimulant use on treatment outcomes amongst individuals initiating medications for opioid use disorders: Secondary analysis of a multisite randomized controlled trial. [PDF]

Drug Alcohol Depend Rep
Coles C, Batts C, Bae J, León G, Schmidt A, McPherson SM, Smith CL, Miguel AC.   +7 more
europepmc   +1 more source

Interindividual variability in the prevalence of OPRM1 and CYP2B6 gene variations may identify drug-susceptible populations [PDF]

, 2011
Bunten, Hannah, Liang, Wei-Jun, Osselton, David M., Pounder, Derrick   +3 more
core